Blood PressureNCT07790458
Automated Non-Invasive Blood Pressure Study
An observational study of Blood Pressure and Blood Pressure Measurement, run by GE Healthcare at 2 sites in Finland.
Trial summary
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Blood Pressure, Blood Pressure Measurement
- How many people
- 50 participants
- Where
- 2 sitesFinland
- Study dates
- 14 Apr 2025to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients treated in Meilahti hospital
Who may be able to join
- Able to provide written informed consent or have a LDR to provide written informed consent;
- Are being cared for in OR, PACU or ICU and are expected to remain in the unit for the duration of the study procedure;
- Have an invasive blood pressure measurement as a standard of care; AND
- Are 18 years of age or older.
Who cannot join
- Are known to be pregnant;
- Are breastfeeding;
- Are suffering from infection(s) that require isolation; OR
- Have an external heart assistant device.
- PI or caring physician decision due to subject health condition
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Finland2 sites, 2 recruiting
- Not yet recruiting
Helsinki University Hospital
Helsinki, 00290
Erika Wilkman Principal Investigator, +35894711, erika.wilkman@hus.fi
- Recruiting
Helsinki University Hospital
Helsinki, 00290
Erika Wilkman Principal Investigator, + 35894711, erika.wilkman@hus.fi
About this study
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
Read the detailed description
Patient monitoring of blood pressure is essential for patient safety in hospitals. Automated non-invasive blood pressure (NIBP) uses data recorded with an SpO2 pulse oximeter to calculate a continuous estimate of blood pressure changes.
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
This study will collect data for development of automated rules and evaluation of their performances in various clinical settings and to develop a larger clinical trial.
- Conditions
- Blood Pressure, Blood Pressure Measurement
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary Outcome Measure
The primary outcome is to collect SpO2 data using Automated Non-Invasive Blood Pressure from subjects in ICU, OR and PACU environment using the investigational system. This data will be used for engineering development purposes.
Measured: Up to 24 hours after time of enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Aug 2026
- Study start14 Apr 2025
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood PressureStudies of the same condition, open and under way.
- More trials run by GE HealthcareThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- GE Healthcare
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07790458
- Sponsor's protocol ID
- 225908091
- Status last verified
- Aug 2026
- First submitted
- 31 Mar 2025
- Last updated
- 27 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Automated Non-Invasive Blood Pressure Study
- ClinicalTrials.gov ID
- NCT07790458
- Acronym / sponsor ID
- 225908091
- Conditions
- Blood Pressure, Blood Pressure Measurement
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- GE HealthcareIndustry (pharma, biotech, devices)
- Study start
- 14 Apr 2025 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 27 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
Detailed description
Patient monitoring of blood pressure is essential for patient safety in hospitals. Automated non-invasive blood pressure (NIBP) uses data recorded with an SpO2 pulse oximeter to calculate a continuous estimate of blood pressure changes.
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
This study will collect data for development of automated rules and evaluation of their performances in various clinical settings and to develop a larger clinical trial.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients treated in Meilahti hospital
Key inclusion criteria (4 listed)
- Able to provide written informed consent or have a LDR to provide written informed consent;
- Are being cared for in OR, PACU or ICU and are expected to remain in the unit for the duration of the study procedure;
- Have an invasive blood pressure measurement as a standard of care; AND
- Are 18 years of age or older.
Key exclusion criteria (5 listed)
- Are known to be pregnant;
- Are breastfeeding;
- Are suffering from infection(s) that require isolation; OR
- Have an external heart assistant device.
- PI or caring physician decision due to subject health condition
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Primary Outcome Measure
Time frame: Up to 24 hours after time of enrollment
The primary outcome is to collect SpO2 data using Automated Non-Invasive Blood Pressure from subjects in ICU, OR and PACU environment using the investigational system. This data will be used for engineering development purposes.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Blood Pressure
Not yet recruiting
Effects of Smartphone Use and Television Viewing on Standardized BP Measurement: The SCREENS-BP Study
Hypertension
RecruitingPhase 4
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
Cerebrovascular Disorders
Recruiting
The Effect of Web-Based Simulation and Flipped Learning on Blood Pressure Education
Education, Education Nursing
Not yet recruiting
Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions
Blood Pressure Measurement
Not yet recruiting
Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy
Hypertensive Disorders of Pregnancy (HDP), Hypertension, Pregnancy Induced
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Blood Pressure and Blood Pressure Measurement, run by GE Healthcare at 2 sites in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Erika Wilkman Principal Invastigator (+35894711, erika.wilkman@hus.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary Outcome Measure (time frame: Up to 24 hours after time of enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.